Radiat Oncol J.  2013 Dec;31(4):260-266. 10.3857/roj.2013.31.4.260.

Stereotactic body radiotherapy for solitary spine metastasis

Affiliations
  • 1Department of Radiation Oncology, Sun Medical Center, Daejeon, Korea. sunlight1018@hanmail.net
  • 2Department of Radiation Oncology, Ajou University School of Medicine, Suwon, Korea.
  • 3Department of Radiation Oncology, Eulji Universtiy School of Medicine, Daejeon, Korea.

Abstract

A clear consensus has not been established regarding the best treatment for solitary bone metastasis. Here, we reviewed the medical records of patients with a controlled primary malignancy who had only solitary spine metastasis without metastasis to the extraspinal bone or viscera and underwent treatment between April 2007 and December 2012 with stereotactic body radiosurgery using CyberKnife, with a total dose of 24 Gy in three to four fractions. During that time, there were only four cases. This was effective in each case, and all the four patients had no local failure and remained alive at a median follow-up of 68 months (range, 64 to 80 months). Although our experience is limited, this study suggests that stereotactic body radiotherapy could be a feasible, safe, effective, and noninvasive alternative treatment for solitary spine metastasis in patients who are medically inoperable or unsuitable for surgery.

Keyword

Stereotactic body radiotherapy; Solitary spine metastasis; Radiation therapy; Local control

MeSH Terms

Consensus
Follow-Up Studies
Humans
Medical Records
Neoplasm Metastasis*
Radiosurgery*
Spine*
Viscera
Full Text Links
  • ROJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr